$14.21 -$0.39 (0.0%)

04:30 PM EDT on 05/20/19

Innoviva Inc. (NASDAQ:INVA)

CAPS Rating: 5 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Current Price $14.21 Mkt Cap $1.5B
Open $14.56 P/E Ratio 0.00
Prev. Close $14.21 Div. (Yield) $0.00 (0.0%)
Daily Range $14.14 - $14.57 Volume 484,307
52-Wk Range $13.07 - $20.53 Avg. Daily Vol. 24

Caps

How do you think NASDAQ:INVA will perform against the market?

Add Stock to CAPS Watchlist

All Players

112 Outperform
29 Underperform
 

All-Star Players

34 Outperform
6 Underperform
 

Wall Street

10 Outperform
0 Underperform
 

Top NASDAQ:INVA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SaintCroix (99.33)
Submitted January 14, 2018

Just started researching this stock. The numbers are kind of insane!p.e. (trailing) 17p.e. (forward) 7PEG 0.27profit margin 52%and the growth is fantasticcurrent year 103%next year 79%next five years 49%and on top of all this, 65% of shares are sold… More

zzlangerhans (99.81)
Submitted September 25, 2010

The recent bull charge has carried several baby biotechs and small pharmas out of their trading range without positive catalysts, which primes them for disproportionate drops as soon as the momentum inevitably shifts. Theravance has been bouncing… More

NASDAQ:INVA VS S&P 500 (SPY)

Fools bullish on NASDAQ:INVA are also bullish on:

Fools bearish on NASDAQ:INVA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about INVA.

Recs

0
Member Avatar BernieRosa (83.21) Submitted: 1/8/2019 7:23:36 PM : Outperform Start Price: $19.00 NASDAQ:INVA Score: -35.55

Grow and more Grow!

Recs

1
Member Avatar SaintCroix (99.33) Submitted: 1/14/2018 12:03:16 AM : Outperform Start Price: $14.52 NASDAQ:INVA Score: -3.87

Just started researching this stock. The numbers are kind of insane!

p.e. (trailing) 17
p.e. (forward) 7
PEG 0.27
profit margin 52%

and the growth is fantastic

current year 103%
next year 79%
next five years 49%

and on top of all this, 65% of shares are sold short?

Recs

0
Member Avatar LovinMe (29.10) Submitted: 11/30/2014 7:42:02 PM : Outperform Start Price: $14.48 NASDAQ:INVA Score: -39.56

Pharma isn't my favorite but I do like the valuation and dividend on this. Not without it's risks.

Leaderboard

Find the members with the highest scoring picks in INVA.

Score Leader

Evad005

Evad005 (< 20) Score: +237.47

The Score Leader is the player with the highest score across all their picks in INVA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Evad005 < 20 3/25/2009 Underperform 3M $12.24 +16.05% +253.52% +237.47 0 Comment
jmacn22 30.07 2/5/2009 Underperform 3Y $11.97 +18.76% +241.15% +222.39 1 Comment
anticitradeshort 36.87 4/20/2009 Underperform NS $10.36 +37.15% +235.70% +198.55 0 Comment
qubit15 21.49 1/21/2009 Underperform NS $8.07 +76.19% +255.09% +178.90 0 Comment
schwah4 29.64 12/29/2008 Underperform NS $8.23 +72.73% +237.45% +164.72 0 Comment
haimp 27.00 10/7/2010 Underperform 5Y $15.87 -10.43% +145.32% +155.75 0 Comment
sandramartin < 20 3/19/2007 Underperform 3M $22.22 -36.06% +115.76% +151.82 0 Comment
withoutlimits 83.63 10/1/2010 Underperform 5Y $14.84 -4.26% +147.15% +151.41 1 Comment
alexdowns77 93.21 10/1/2010 Underperform 5Y $14.54 -2.27% +148.56% +150.83 0 Comment
star60629 27.78 5/1/2007 Underperform 5Y $24.18 -41.23% +102.43% +143.66 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackBernstein 88.77 4/24/2013 Outperform NS $22.78 -37.61% +80.07% -117.67 0 Comment
TrackZacks < 20 7/11/2012 Outperform 3M $29.32 -4.30% +2.82% -7.11 8/1/2012 @ $28.06 1 Comment
TrackBreanMurray 53.06 3/12/2012 Outperform NS $13.42 +5.87% +106.62% -100.75 0 Comment
TrackZacks < 20 1/12/2012 Underperform 3M $17.67 +2.43% +4.39% +1.95 2/14/2012 @ $18.10 1 Comment
TrackZacks < 20 8/2/2011 Underperform 3M $18.54 +12.14% -3.16% -15.30 9/16/2011 @ $20.79 1 Comment
TrackSwensen < 20 12/31/2010 Outperform NS $18.45 -22.97% +126.98% -149.95 0 Comment
trackthinkequity 92.51 2/20/2009 Outperform NS $11.97 +18.76% +277.06% -258.30 0 Comment
TrackRWBaird 87.70 2/5/2009 Outperform NS $15.88 +40.68% +57.71% -17.03 6/3/2011 @ $22.34 0 Comment
TrackSusquehanna 87.26 9/5/2008 Outperform NS $9.77 +45.52% +137.74% -92.22 0 Comment
TrackStanfordRes < 20 10/26/2007 Outperform NS $23.80 -13.57% -9.33% -4.25 4/17/2012 @ $20.57 0 Comment
TrackEveillard 93.39 9/30/2007 Outperform NS $26.09 -59.64% -13.94% -45.70 3/31/2008 @ $10.53 1 Comment
TrackCowenandCo 77.83 8/21/2007 Outperform NS $21.40 -33.60% +106.89% -140.49 0 Comment
TrackCreditSuiss 89.36 4/27/2007 Outperform NS $33.23 -80.71% -37.08% -43.63 10/29/2008 @ $6.41 0 Comment
TrackJimCramer 85.94 4/9/2007 Outperform 3W $22.43 -36.64% +108.02% -144.67 0 Comment
TrackHSBC < 20 2/9/2007 Outperform NS $26.14 -45.63% +107.95% -153.59 0 Comment
TrackRodmanRen < 20 2/9/2007 Outperform NS $26.14 -45.63% +107.95% -153.59 0 Comment
TrackPiperJaff 85.87 12/19/2006 Outperform NS $22.66 -37.28% +113.29% -150.57 0 Comment

Advertisement